TECX

Tectonic Therapeutic (TECX)

About Tectonic Therapeutic (TECX)

Tectonic Therapeutic, Inc. is a clinical-stage biotechnology company, which engages in the discovery and development of therapeutic proteins and antibodies that modulate the activity of G protein-coupled receptors (GPCR). It develops a proprietary technology platform called GEODe to enable the discovery and development of GPCR-targeted biologic medicines. The company was founded by Timothy A. Springer and Andrew Kruse in November 2015 and is headquartered in Watertown, MA.

Details

Daily high

$31.22

Daily low

$30.25

Price at open

$30.26

52 Week High

$36.03

52 Week Low

$13.70

Market cap

564.6M

Dividend yield

0.00%

Volume

21,788

Avg. volume

359,406

P/E ratio

-7.44

Tectonic Therapeutic News